Company / EPS (Diluted)
Tanke Biosciences Corp EPS (Diluted) History
FY2011-FY2012 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.24
FY2012
5-year range
-$0.24 / $0.34
FY2011-FY2012
Trend
-170.6%
vs FY2011
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-0.24 in FY2012.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2012, eps (diluted) decreased 170.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2012 | -$0.24 | -170.6% |
| FY2011 | $0.34 | - |
As of FY2012 · SEC 10-K · Updated Jun 29, 2026